Cargando…

SPARC Expression Is Selectively Suppressed in Tumor Initiating Urospheres Isolated from As(+3)- and Cd(+2)-Transformed Human Urothelial Cells (UROtsa) Stably Transfected with SPARC

BACKGROUND: This laboratory previously analyzed the expression of SPARC in the parental UROtsa cells, their arsenite (As(+3)) and cadmium (Cd(+2))-transformed cell lines, and tumor transplants generated from the transformed cells. It was demonstrated that SPARC expression was down-regulated to backg...

Descripción completa

Detalles Bibliográficos
Autores principales: Slusser-Nore, Andrea, Larson-Casey, Jennifer L., Zhang, Ruowen, Zhou, Xu Dong, Somji, Seema, Garrett, Scott H., Sens, Donald A., Dunlevy, Jane R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4718619/
https://www.ncbi.nlm.nih.gov/pubmed/26783756
http://dx.doi.org/10.1371/journal.pone.0147362
_version_ 1782410826719690752
author Slusser-Nore, Andrea
Larson-Casey, Jennifer L.
Zhang, Ruowen
Zhou, Xu Dong
Somji, Seema
Garrett, Scott H.
Sens, Donald A.
Dunlevy, Jane R.
author_facet Slusser-Nore, Andrea
Larson-Casey, Jennifer L.
Zhang, Ruowen
Zhou, Xu Dong
Somji, Seema
Garrett, Scott H.
Sens, Donald A.
Dunlevy, Jane R.
author_sort Slusser-Nore, Andrea
collection PubMed
description BACKGROUND: This laboratory previously analyzed the expression of SPARC in the parental UROtsa cells, their arsenite (As(+3)) and cadmium (Cd(+2))-transformed cell lines, and tumor transplants generated from the transformed cells. It was demonstrated that SPARC expression was down-regulated to background levels in Cd(+2)-and As(+3)-transformed UROtsa cells and tumor transplants compared to parental cells. In the present study, the transformed cell lines were stably transfected with a SPARC expression vector to determine the effect of SPARC expression on the ability of the cells to form tumors in immune-compromised mice. METHODS: Real time PCR, western blotting, immunohistochemistry, and immunofluorescence were used to define the expression of SPARC in the As(+3)-and Cd(+2)-transformed cell lines, and urospheres isolated from these cell lines, following their stable transfection with an expression vector containing the SPARC open reading frame (ORF). Transplantation of the cultured cells into immune-compromised mice by subcutaneous injection was used to assess the effect of SPARC expression on tumors generated from the above cell lines and urospheres. RESULTS: It was shown that the As(+3)-and Cd(+2)-transformed UROtsa cells could undergo stable transfection with a SPARC expression vector and that the transfected cells expressed both SPARC mRNA and secreted protein. Tumors formed from these SPARC-transfected cells were shown to have no expression of SPARC. Urospheres isolated from cultures of the SPARC-transfected As(+3)-and Cd(+2)-transformed cell lines were shown to have only background expression of SPARC. Urospheres from both the non-transfected and SPARC-transfected cell lines were tumorigenic and thus fit the definition for a population of tumor initiating cells. CONCLUSIONS: Tumor initiating cells isolated from SPARC-transfected As(+3)-and Cd(+2)-transformed cell lines have an inherent mechanism to suppress the expression of SPARC mRNA.
format Online
Article
Text
id pubmed-4718619
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-47186192016-01-30 SPARC Expression Is Selectively Suppressed in Tumor Initiating Urospheres Isolated from As(+3)- and Cd(+2)-Transformed Human Urothelial Cells (UROtsa) Stably Transfected with SPARC Slusser-Nore, Andrea Larson-Casey, Jennifer L. Zhang, Ruowen Zhou, Xu Dong Somji, Seema Garrett, Scott H. Sens, Donald A. Dunlevy, Jane R. PLoS One Research Article BACKGROUND: This laboratory previously analyzed the expression of SPARC in the parental UROtsa cells, their arsenite (As(+3)) and cadmium (Cd(+2))-transformed cell lines, and tumor transplants generated from the transformed cells. It was demonstrated that SPARC expression was down-regulated to background levels in Cd(+2)-and As(+3)-transformed UROtsa cells and tumor transplants compared to parental cells. In the present study, the transformed cell lines were stably transfected with a SPARC expression vector to determine the effect of SPARC expression on the ability of the cells to form tumors in immune-compromised mice. METHODS: Real time PCR, western blotting, immunohistochemistry, and immunofluorescence were used to define the expression of SPARC in the As(+3)-and Cd(+2)-transformed cell lines, and urospheres isolated from these cell lines, following their stable transfection with an expression vector containing the SPARC open reading frame (ORF). Transplantation of the cultured cells into immune-compromised mice by subcutaneous injection was used to assess the effect of SPARC expression on tumors generated from the above cell lines and urospheres. RESULTS: It was shown that the As(+3)-and Cd(+2)-transformed UROtsa cells could undergo stable transfection with a SPARC expression vector and that the transfected cells expressed both SPARC mRNA and secreted protein. Tumors formed from these SPARC-transfected cells were shown to have no expression of SPARC. Urospheres isolated from cultures of the SPARC-transfected As(+3)-and Cd(+2)-transformed cell lines were shown to have only background expression of SPARC. Urospheres from both the non-transfected and SPARC-transfected cell lines were tumorigenic and thus fit the definition for a population of tumor initiating cells. CONCLUSIONS: Tumor initiating cells isolated from SPARC-transfected As(+3)-and Cd(+2)-transformed cell lines have an inherent mechanism to suppress the expression of SPARC mRNA. Public Library of Science 2016-01-19 /pmc/articles/PMC4718619/ /pubmed/26783756 http://dx.doi.org/10.1371/journal.pone.0147362 Text en https://creativecommons.org/publicdomain/zero/1.0/ This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 (https://creativecommons.org/publicdomain/zero/1.0/) public domain dedication.
spellingShingle Research Article
Slusser-Nore, Andrea
Larson-Casey, Jennifer L.
Zhang, Ruowen
Zhou, Xu Dong
Somji, Seema
Garrett, Scott H.
Sens, Donald A.
Dunlevy, Jane R.
SPARC Expression Is Selectively Suppressed in Tumor Initiating Urospheres Isolated from As(+3)- and Cd(+2)-Transformed Human Urothelial Cells (UROtsa) Stably Transfected with SPARC
title SPARC Expression Is Selectively Suppressed in Tumor Initiating Urospheres Isolated from As(+3)- and Cd(+2)-Transformed Human Urothelial Cells (UROtsa) Stably Transfected with SPARC
title_full SPARC Expression Is Selectively Suppressed in Tumor Initiating Urospheres Isolated from As(+3)- and Cd(+2)-Transformed Human Urothelial Cells (UROtsa) Stably Transfected with SPARC
title_fullStr SPARC Expression Is Selectively Suppressed in Tumor Initiating Urospheres Isolated from As(+3)- and Cd(+2)-Transformed Human Urothelial Cells (UROtsa) Stably Transfected with SPARC
title_full_unstemmed SPARC Expression Is Selectively Suppressed in Tumor Initiating Urospheres Isolated from As(+3)- and Cd(+2)-Transformed Human Urothelial Cells (UROtsa) Stably Transfected with SPARC
title_short SPARC Expression Is Selectively Suppressed in Tumor Initiating Urospheres Isolated from As(+3)- and Cd(+2)-Transformed Human Urothelial Cells (UROtsa) Stably Transfected with SPARC
title_sort sparc expression is selectively suppressed in tumor initiating urospheres isolated from as(+3)- and cd(+2)-transformed human urothelial cells (urotsa) stably transfected with sparc
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4718619/
https://www.ncbi.nlm.nih.gov/pubmed/26783756
http://dx.doi.org/10.1371/journal.pone.0147362
work_keys_str_mv AT slussernoreandrea sparcexpressionisselectivelysuppressedintumorinitiatingurospheresisolatedfromas3andcd2transformedhumanurothelialcellsurotsastablytransfectedwithsparc
AT larsoncaseyjenniferl sparcexpressionisselectivelysuppressedintumorinitiatingurospheresisolatedfromas3andcd2transformedhumanurothelialcellsurotsastablytransfectedwithsparc
AT zhangruowen sparcexpressionisselectivelysuppressedintumorinitiatingurospheresisolatedfromas3andcd2transformedhumanurothelialcellsurotsastablytransfectedwithsparc
AT zhouxudong sparcexpressionisselectivelysuppressedintumorinitiatingurospheresisolatedfromas3andcd2transformedhumanurothelialcellsurotsastablytransfectedwithsparc
AT somjiseema sparcexpressionisselectivelysuppressedintumorinitiatingurospheresisolatedfromas3andcd2transformedhumanurothelialcellsurotsastablytransfectedwithsparc
AT garrettscotth sparcexpressionisselectivelysuppressedintumorinitiatingurospheresisolatedfromas3andcd2transformedhumanurothelialcellsurotsastablytransfectedwithsparc
AT sensdonalda sparcexpressionisselectivelysuppressedintumorinitiatingurospheresisolatedfromas3andcd2transformedhumanurothelialcellsurotsastablytransfectedwithsparc
AT dunlevyjaner sparcexpressionisselectivelysuppressedintumorinitiatingurospheresisolatedfromas3andcd2transformedhumanurothelialcellsurotsastablytransfectedwithsparc